The 72nd Annual Workers' Compensation Educational Conference and 29th Annual Safety & Health Conference (WCI 360) The WCI360 Conference focuses on national workers’ compensation and occupational safety and health industries. During the 72nd Conference, speakers will present on issues of common concern to all Workers’ Comp professionals, regardless of jurisdiction or state, issues that have no geographical boundaries. Mitchell’s is pleased to participate as an exhibitor at the Conference with information on our Workers’ Compensation and Pharmacy Solutions. Our team will be onsite for booth demos, 1x1 meetings and a small meet and greet for our Pharmacy Solutions team. Please contact your Mitchell representative for more detail.
More stories
Destination Care
Destination care, centers of excellence, medical tourism, benefit driven travel and geographically recognized care centers – mean what exactly? And if the concept is quickly growing in popularity for group health patients, can it be applied for workers’ compensation claimants too?
The Power of Technology Enabled Services: Balancing Technology with the Human Touch
While technology and automation have dominated the conversation in the insurance industry for the past few years, it is important that the property and casualty industry understands the importance of digitizing while maintaining the element of human touch in claims processing.
Puerto Rico Governor Declares State of Emergency
Updates to how injured workers can access care in the wake of a 6.4 magnitude earthquake in Puerto Rico.
Lisa Anne Bickford IAIABC Appointment
Lisa Anne Bickford IAIABC Appointment
WHY USE ANTICONVULSANTS TO TREAT PAIN?
A fuller awareness of the risks, costs, and consequences of opioid medication use in clinical pain management is growing, and the search for safe, effective, and affordable alternatives to them has taken on new urgency. The quest for opioid alternatives that offer a measure of effective analgesia (without craving, tolerance, and addiction) is taking on an increased priority in discovery laboratories and across the ranks of practicing clinicians and other health care professionals. Beyond new discovery, another potential source of such alternatives is in reevaluating existing medications approved for pain as well as those approved for other uses that may also hold promise for use as analgesics.